Peer Review History
| Original SubmissionMay 27, 2023 |
|---|
|
PONE-D-23-16303A Reliable Forecast Tool for the Changing Face of DenguePLOS ONE Dear Dr. Jayathilaka, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 09 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mohamed R. Abonazel, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and Additional Editor Comments: The authors are requested to make appropriate modifications to this manuscript as suggested by the reviewers. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1. The modeling and the method of doing and reporting it are approved, but it is necessary to report and prepare the article based on the guidelines of the journal. 2. The Literature Review section should be removed and it is better to integrate it in the introduction as a summary 3. Figure 6 and 7 should be merged. 4. What is the reason for the difference between the actual and predicted values in Figure 8? 5. Goodness-of-fit of the final model such as AIC,BIC, normality of the residuals, mean absolute percentage error (MAPE) index, etc. should be reported. 6. The article is long, it should be written more concisely Reviewer #2: The authors have focused on accurately forecasting dengue infections by utilizing historical data on infected cases. To achieve this, they have employed statistical models presented in time series analysis. Based on the data collected in the Colombo district, Sri Lanka, the manuscript concludes that ARIMA models are suitable for dengue forecasting. The current title of the manuscript does not clearly reflect the objective/s. The phrase "Changing face of dengue" in the title implies a different meaning than what the authors intended. Therefore, the title should be changed to align appropriately with the content. However, the abstract has properly summarized the content and the objectives, and the conclusion of the study. The graphics included in the manuscript are often in the form of pictures instead of vector images, which has led to a decrease in image clarity and quality. Additionally, software-generated outputs have been directly presented as tables, as evident in Table 3. This approach results in the overcrowding of information within a single table, leading to poor clarity and readability. In the literature review, various models used in dengue forecasting have been discussed. However, there is an insufficient presentation regarding the application of ARIMA/AR models in dengue forecasting, despite them being the underlying models used in the current research. The keywords: ARIMA + "Dengue forecasting" resulted in numerous related articles. In dengue cases forecasting, a weekly resolution of the data is considered suitable for time series analysis. Therefore, the study utilizes appropriate secondary data for its analysis. Since the ARIMA and AR models are standard models, a detailed description is not necessary. The authors can provide a concise introduction to these models in the introduction section. Generally, a comprehensive explanation of fundamental time series techniques is not expected in an article of this nature. Thus, it is strongly recommended to condense the details and cite relevant content for further clarification. Additionally, the authors have used notations without properly introducing them in advance (refer to lines 173, 174). There are many typing mistakes visible in the manuscript; refer to lines 61 and 98. Further, sentence structure has to be improved. As mentioned previously, the existing literature discusses the appropriateness of using ARIMA models for dengue forecasting. However, the suitability of applying ARIMA models to the specific dataset may not have been thoroughly investigated. Given that dengue dynamics are influenced by the interactions between vectors and humans, it is reasonable to assume that ARIMA models could be applicable to the underlying dataset. To truly contribute to the existing literature and establish novelty in the research, it is important for the authors to present significant results that demonstrate the adequacy of the ARIMA models rather than solely focusing on model diagnostic results. One approach to achieve this is by analyzing the robustness and stability of the ARIMA model(s) in forecasting dengue cases across different contexts. For example, examining the accuracy of forecasting extreme events such as the peak of dengue incidents in 2017. Neglecting to address these aspects raises doubts about the novelty of the present study. The findings should go beyond simply fitting a time series model to a given dataset. The results should provide meaningful insights into the forecasting capabilities of ARIMA models for dengue, as ARIMA is not new in dengue case forecasting. Based on the issues that have been highlighted regarding the novelty, contribution, clarity, and structure of the manuscript, it seems that significant revisions and improvements are necessary for it to be considered suitable for publication. It's important to address these concerns and make the necessary enhancements to ensure the manuscript meets the standards expected in the field. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-16303R1Forecasting Weekly Dengue Incidence in Sri Lanka: Modified Autoregressive Integrated Moving Average Modeling ApproachPLOS ONE Dear Dr. Jayathilaka, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 17 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mohamed R. Abonazel, Ph.D. Academic Editor PLOS ONE Additional Editor Comments: -To ensure that the estimated model fits the data, the authors should perform the test of normality of the residuals as a required diagnostic test for the ARIMA model. See https://doi.org/10.28919/cmbn/6888, https://doi.org/10.1371/journal.pone.0250149. and https://doi.org/10.12988/ref.2019.81023 for the diagnostic tests of ARIMA models. -There are some grammatical and spelling errors in the paper, the authors need to carefully check the full text. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #3: (No Response) Reviewer #4: (No Response) Reviewer #5: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: No Reviewer #5: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: No Reviewer #4: N/A Reviewer #5: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: No Reviewer #4: Yes Reviewer #5: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: No Reviewer #5: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you, all my comments in the previous step have been well answered by the authors. There are no comments and the article can be published Reviewer #3: My primary concern is with respect to clarity around the evaluation. Specifically, the authors need to: (1) Establish a common sense baseline for comparison in Figure 1. For example how accurate would a model be that predicted the next week of cases would the same as the last. Would this outperform the ARIMA (2,1,0) model. If so what other advantages would the ARIMA (2,1,0) model hold. (2) The authors identify three ARIMA candidate models [(0,1,2), (2,1,0), and (2,1,2)] for consideration. Two are deemed invalid because they do not match theoretical assumptions. However, readers will be curious if they would outperform the ARIMA (2,1,0) model in the evaluation. Including this data in the evaluation and discussing it would improve the paper. (3) Furthermore, showing that the ARIMA(2,1,0) outperforms the ARIMA alternatives and the common sense baseline by a statistically significant margin would strengthen the contribution of the paper a great deal. This would demonstrate that the ARIMA(2,1,0) approach is materially more accurate than the alternatives and that improved accuracy will generalize. (4) The authors use one training/evaluation split for the data. The results are a little uninspiring as the forecast data does match the actual data in terms of data points or shapes. Were other training/evaluation splits considered. If so, was the performance ever better than what was shown. The paper would benefit from a larger presentation of different splits (i.e. more training data, less training data, conclusions about accuracy w.r.t. training data). In addition, the paper would benefit from a discussion of limitations. As it currently stands it appears as if all projections are made at the same geographic level. Identifying that research (see paper below) has shown that effective time series projections of viruses can depend on the geographic-level of evaluation (i.e country vs. city vs. county vs. neighborhood). Identifying exactly which of these units is used in the paper (i.e. country) and explicitly stating that changing this context might change the results of the analysis and the conclusions would help readers understand the context in which the results will generalize. Lynch, Christopher J., et al. "Short-range forecasting of COVID-19 during early onset at county, health district, and state geographic levels using seven methods: comparative forecasting study." Journal of medical Internet research 23.3 (2021): e24925. (5) The numbers in Q-STAT column of Figures 2 and 4 in the paper are difficult to compare to one another because the numbers are not right justified. As a result, the significant digits of the numbers are not aligned on top of one another (i.e. 100ths, 10ths, etc.) Right justifying the numbers in the table will improve readability and enable readers to compare results between rows. For the data availability, the text points at Supporting Information 1. However, all that is included is the case data. Including the raw data for the analyses done to chose the model as well as the source code used to build the models, tables and plots in the paper would improve the availability of data for the paper. Reviewer #4: The manuscript does not state why forecasting weekly dengue virus (DENV) incidence is essential for preventive and therapeutic purposes. DENV outbreaks in endemic countries, most of the time, follow seasonal patterns and just retrospectively inspecting epidemiologically data is enough to identify critical periods and consequently work on preparedness. Just looking figure 6, I don't find any benefit comparing predictions and real data. Unfortunately the structure of this manuscript is not helpful understanding the usefulness of predicting weekly incidence. I would expected a reliable justification (e.g., identify hotspots to invest in infrastructure or human resources) but authors just mention an information gap. In the lack of sound rationale, I found very difficult to provide specific feedback to improve the manuscript. Broadly, these are major observations: 1. The introduction section should follow a conventional structure: disease burden, knowledge gap, how the gap was tackled previously, and the aims of this manuscript to tackle the gap innovately. Instead of that, irrelevant aspects are discussed (how virulence or new strains could be identified by using this model?), using non-conventional terms (ferocity?), and use interchangeably (but erroneously) basic epidemiolgical concepts (incidence and prevalence). For example, in DENV, how prevalence could help improving prevention and treatment? Are you referring to seroprevalence? It is unreasonable to measure DENV prevalence as this is not a chronic infection. Authors should clearly state how weekly DENV incidence prediction will impact prevention/treatment. 2. Unless dictated by the editors, results and discussion should be separate sections. 3. Page 17, "Four dengue virus serotypes have been reported, marked as DENV 1 – 4. One of those serotypes predominated the outbreaks in specific years [20]. Since the severity of an epidemic tends to be associated with its serotype, mathematical modelling can be a reliable tool to make hypotheses about the emergence of new strains.": this is incorrect. Disease severity is explained by the ocurrence of secondary heterologous infections and inadequate medical interventions. Thus, the best way to predict severity is to conduct seroprevalence studies complemented by sentinel surveillance to identify different serotypes. I don't find any rationale in using this model to hypothesise new strains. 4. Policy implementation section: how forecasting weekly DENV incidence could complement or replace (partially or totally) epidemiologic surveillance? As shown in figure 6, I don't find any benefit simply inspecting retrospectively data compared with the modelling conducted by authors. Due to historical trends, endemic countries are well-informed of critical periods and simply introducing preventive actions before this periods could change morbidity and mortality. Unfortunately, politics and government priorities are out of the scope of this manuscript, authors should realise that mortality/morbidity is consequence of government passivity and not by gaps in information. Reviewer #5: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No Reviewer #4: No Reviewer #5: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-23-16303R2Forecasting Weekly Dengue Incidence in Sri Lanka: Modified Autoregressive Integrated Moving Average Modeling ApproachPLOS ONE Dear Dr. Jayathilaka, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Comments from PLOS Editorial Office: We note that the Academic Editor and one or more reviewers has recommended that you cite specific previously published works. As always, we recommend that you please review and evaluate the requested works to determine whether they are relevant and should be cited. It is not a requirement to cite these works. We note that your previous response to comments by Reviewer 3 indicates you considered the reviewer's suggested citation to be relevant; please clarify this if needed in light of the further comments by Reviewer 3 appended below. We appreciate your attention to this request. Please submit your revised manuscript by Jan 29 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mohamed R. Abonazel, Ph.D. Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: (No Response) Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #3: In the response to reviewers letter the authors state, "Furthermore, we have made a conscientious effort to reference pertinent research, including the work by Lynch et al. (2021), in order to underscore the critical importance of taking into account the geographic level in the domain of virus forecasting." However, this reference does not appear in the newly added 'Limitations of the Study' section of the paper which was meant to address the concern identified in the reference and it does not appear elsewhere in the paper. The paper needs to be revised to be consistent with the modifications the authors have described in the response to reviewers letter. Reviewer #4: I don't think my first and third comments were resolved. The introduction still discusses irrelevant aspects and inaccurately attempts to justify the usefulness of forecasting dengue incidence (prevalence is still used). Regarding my third comment, I'm afraid I disagree that severity, which is an eminently clinical definition, should be interpreted in terms of disease impact or consequences. Those aspects are the burden of disease, and it is not justifiable to use disease burden and disease severity interchangeably. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Ok Reviewer #3: Yes: Ross J. Gore Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Forecasting Weekly Dengue Incidence in Sri Lanka: Modified Autoregressive Integrated Moving Average Modeling Approach PONE-D-23-16303R3 Dear Dr. Jayathilaka, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mohamed R. Abonazel, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: Yes: Ross J. Gore ********** |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .